Signing in...

  Please verify reCAPTCHA大佬们都在玩{精选官网网址: www.vip333.Co }值得信任的品牌平台!

  Verification expired. Check the checkbox again, please.

  Required field

  Invalid date

  Please enter dates in the format

  Please enter a valid email address

  Please enter a valid number

  Please enter only alphanumeric characters

  Please remove spaces

  Please enter more characters

  Please enter less characters

  Please enter a valid phone number e.g. +18885872280

  Please enter valid JSON

  Please enter valid RegExp

  {{item}} saved.

  Delete {{item}}?

  Remove {{item}}?

  {{item}} deleted.

  {{item}} removed.

  {{item}} enabled.大佬们都在玩{精选官网网址: www.vip333.Co }值得信任的品牌平台!

  Not allowed columns: {{#columns}}{{.}}{{/columns}}

  Study for patient {{patient_name}} was sent to PACS {{pacs_name}}

  Please select at least one activity.

  Please select at least one {{type}} activity.

  Study for {{PatientName}} was shared successfully with {{destinationName}}.

  Modality {{ modality }} already has a price

  Password for {{ username }} has been reset

  Please select at least one share.

  Study shares successfully removed.

  Please accept agreement

  Please accept terms and conditions

  {{patient}} study request status has been changed

  The list of available organizations is empty. Check your organization settings.

  Current price configuration uses custom fields that have been removed. Configuration updates required.

  Patient Name

  Patient Sex

  Patient ID

  DOB

  Accession #

  Study Description

  Referring Physician

  Modality

  Image Count

  {{#customfields}}

  {{name}}

  {{/customfields}}

  Patient Name

  Patient Sex

  Patient ID

  DOB

  Accession #

  Study Description

  Referring Physician

  Study Stage

  Send Status

  Destination name

  Study Date大佬们都在玩{精选官网网址: www.vip333.Co }值得信任的品牌平台!

  Uploaded Date

  Starred

  Thin

  Modality

  Study UID

  Study UUID

  Tags

  {{#orders}}

  Orders

  {{/orders}}

  {{#customfields}}

  {{name}}

  {{/customfields}}

Signing in...

Signing in...

0 51

留言0

评论

◎欢迎参与讨论,请在这里发表您的看法、交流您的观点。